Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet

Bladder cancer (BC) is the most common neoplasia of the urothelial tract. Due to its high incidence, prevalence, recurrence and mortality, it remains an unsolved clinical and social problem. The treatment of BC is challenging and, although immunotherapies have revealed potential benefit in a percent...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Victor G., Munera-Maravilla, Ester, Bernardini, Alejandra, Rubio, Carolina, Suarez-Cabrera, Cristian, Segovia, Cristina, Lodewijk, Iris, Dueñas, Marta, Martínez-Fernández, Mónica, Paramio, Jesus Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902278/
https://www.ncbi.nlm.nih.gov/pubmed/31850055
http://dx.doi.org/10.3389/fgene.2019.01125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902278/
https://www.ncbi.nlm.nih.gov/pubmed/31850055
http://dx.doi.org/10.3389/fgene.2019.01125

Ejemplares similares